Johannes Gutenberg-Universität Mainz
- 6131/39-0
Lurie, Daniel J.; Kessler, Daniel; Bassett, Danielle S. et al.
Questions and controversies in the study of time-varying functional connectivity in resting fMRINETWORK NEUROSCIENCE. Bd. 4. H. 1. 2020 S. 30-69
Bekbulat, Fazilet; Schmitt, Daniel; Feldmann, Anne et al.
RAB18 Loss Interferes With Lipid Droplet Catabolism and Provokes Autophagy Network AdaptationsJOURNAL OF MOLECULAR BIOLOGY. Bd. 432. H. 4. 2020 S. 1216-1234
Loose, Reinhard W.; Vano, Eliseo; Mildenberger, Peter et al.
Radiation dose management systems-requirements and recommendations for users from the ESR EuroSafe Imaging initiativeEUROPEAN RADIOLOGY. 2020
Zahnreich, Sebastian; Roesler, Hans-Peter; Schwanbeck, Carina et al.
Radiation-induced DNA double-strand breaks in peripheral leukocytes and therapeutic response of heel spur patients treated by orthovoltage X-rays or a linear acceleratorSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. 12. 2020 S. 1116-1127
Rades, Dirk; Bartscht, Tobias; Hunold, Peter et al.
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. 9. 2020 S. 795-804
Arendt, Christophe T.; Leithner, Doris; Mayerhoefer, Marius E. et al.
Radiomics of high-resolution computed tomography for the differentiation between cholesteatoma and middle ear inflammation: effects of post-reconstruction methods in a dual-center studyEUROPEAN RADIOLOGY. 2020
Riegel, Kristina; Schloeder, Janine; Sobczak, Marco et al.
RAF kinases are stabilized and required for dendritic cell differentiation and functionCELL DEATH AND DIFFERENTIATION. Bd. 27. H. 4. 2020 S. 1300-1315
Kudo, Masatoshi; Galle, Peter R.; Llovet, Josep M. et al.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2LIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 2008-2020
Zhu, Andrew X.; Ikeda, Masafumi; Galle, Peter R. et al.
Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP): Outcomes by treatment-emergent ascites.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Finn, R. S.; Qin, S-K.; Galle, P. R. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: An expansion cohort of the phase III REACH-2 studyANNALS OF ONCOLOGY. Bd. 31. 2020 S. S702-S702